Log in

NASDAQ:RMTI - Rockwell Medical Stock Price, Forecast & News

$2.57
-0.03 (-1.15 %)
(As of 01/26/2020 07:38 AM ET)
Today's Range
$2.51
Now: $2.57
$2.61
50-Day Range
$2.20
MA: $2.39
$2.83
52-Week Range
$1.81
Now: $2.57
$6.88
Volume155,103 shs
Average Volume385,164 shs
Market Capitalization$164.38 million
P/E RatioN/A
Dividend YieldN/A
Beta1.49
Rockwell Medical, Inc operates as a specialty pharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis. The company offers Triferic, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores; and Calcitriol, an active vitamin D injection for the management of hypocalcemia in patients undergoing chronic hemodialysis. Read More…

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:RMTI
CUSIP77437410
Phone248-960-9009

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$63.39 million
Book Value$0.48 per share

Profitability

Net Income$-32,130,000.00

Miscellaneous

Employees269
Market Cap$164.38 million
Next Earnings Date3/12/2020 (Estimated)
OptionableOptionable

Receive RMTI News and Ratings via Email

Sign-up to receive the latest news and ratings for RMTI and its competitors with MarketBeat's FREE daily newsletter.


Rockwell Medical (NASDAQ:RMTI) Frequently Asked Questions

What is Rockwell Medical's stock symbol?

Rockwell Medical trades on the NASDAQ under the ticker symbol "RMTI."

How were Rockwell Medical's earnings last quarter?

Rockwell Medical Inc (NASDAQ:RMTI) issued its earnings results on Monday, November, 11th. The company reported ($0.12) EPS for the quarter, beating analysts' consensus estimates of ($0.14) by $0.02. The business earned $15.41 million during the quarter, compared to analyst estimates of $15.40 million. Rockwell Medical had a negative return on equity of 139.38% and a negative net margin of 57.77%. View Rockwell Medical's Earnings History.

When is Rockwell Medical's next earnings date?

Rockwell Medical is scheduled to release their next quarterly earnings announcement on Thursday, March 12th 2020. View Earnings Estimates for Rockwell Medical.

What price target have analysts set for RMTI?

4 equities research analysts have issued 1-year price targets for Rockwell Medical's stock. Their forecasts range from $6.00 to $11.00. On average, they anticipate Rockwell Medical's share price to reach $9.33 in the next year. This suggests a possible upside of 263.2% from the stock's current price. View Analyst Price Targets for Rockwell Medical.

What is the consensus analysts' recommendation for Rockwell Medical?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rockwell Medical in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Rockwell Medical.

Has Rockwell Medical been receiving favorable news coverage?

Press coverage about RMTI stock has been trending extremely negative recently, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Rockwell Medical earned a media sentiment score of -4.5 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the immediate future. View News Stories for Rockwell Medical.

Who are some of Rockwell Medical's key competitors?

What other stocks do shareholders of Rockwell Medical own?

Who are Rockwell Medical's key executives?

Rockwell Medical's management team includes the folowing people:
  • Mr. Stuart Paul, Pres, CEO & Director (Age 59)
  • Mr. Angus W. Smith, Chief Financial Officer (Age 36)
  • Dr. Ajay Gupta, Chief Scientific Officer & Member of Scientific Advisory Board (Age 61)
  • Mr. Michael DeYoung, VP of Operations
  • Mr. David J. Kull, Principal Accounting Officer, Sec. & Controller (Age 51)

How do I buy shares of Rockwell Medical?

Shares of RMTI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Rockwell Medical's stock price today?

One share of RMTI stock can currently be purchased for approximately $2.57.

How big of a company is Rockwell Medical?

Rockwell Medical has a market capitalization of $164.38 million and generates $63.39 million in revenue each year. The company earns $-32,130,000.00 in net income (profit) each year or ($0.47) on an earnings per share basis. Rockwell Medical employs 269 workers across the globe.View Additional Information About Rockwell Medical.

What is Rockwell Medical's official website?

The official website for Rockwell Medical is http://www.rockwellmed.com/.

How can I contact Rockwell Medical?

Rockwell Medical's mailing address is 411 HACKENSACK AVENUE SUITE 501, HACKENSACK NJ, 07601. The company can be reached via phone at 248-960-9009 or via email at [email protected]


MarketBeat Community Rating for Rockwell Medical (NASDAQ RMTI)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  266 (Vote Outperform)
Underperform Votes:  292 (Vote Underperform)
Total Votes:  558
MarketBeat's community ratings are surveys of what our community members think about Rockwell Medical and other stocks. Vote "Outperform" if you believe RMTI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RMTI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel